HB 3551 (2021) -  Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease

Appropriations Project by Slosberg-King
Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease: Provides an appropriation for the Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease.
Effective Date: July 1, 2021
Last Event: Vetoed by Governor; See SB 2500 (line item 468) on Wednesday, June 2, 2021 7:13 PM

Referred Committees and Committee Actions

House Referrals

Related Bills

(No Related Bills On Record)

Bill Text

Appropriations Project Request Form

Veto Message

Vetoed by Governor; See SB 2500 (line item 468)

Staff Analysis

(None Available)

Vote History

(No Votes Recorded)

Bill History

Event Time Member Committee Ver.
Event: Vetoed by Governor; See SB 2500 (line item 468) Time: 06/02/2021 - 7:13 PM Member: Committee: Version: __
Event: H See SB 2500 (line item 468) Time: 04/30/2021 - 2:40 PM Member: Committee: Version: __
Event: H 1st Reading Time: 03/02/2021 - 9:21 PM Member: Committee: Version: __
Event: H Now in Health Care Appropriations Subcommittee Time: 02/14/2021 - 9:24 AM Member: Committee: Health Care Appropriations Subcommittee Version: __
Event: H Referred to Appropriations Committee Time: 02/14/2021 - 9:24 AM Member: Committee: Appropriations Committee Version: __
Event: H Referred to Health Care Appropriations Subcommittee Time: 02/14/2021 - 9:24 AM Member: Committee: Health Care Appropriations Subcommittee Version: __
Event: H Filed Time: 02/09/2021 - 12:33 PM Member: Slosberg-King Committee: Version: __